Alphabet (GOOGL) Stock Down on New Medical Technology

NEW YORK (TheStreet) — Alphabet  (GOOGL)  stock is down 0.72% to $706.16 today as the company begins a venture with the U.K. government’s National Health Service to train its technology to detect eye defects and possibly prevent vision loss. Google DeepMind, the company’s London-based artificial intelligence division, will use artificial intelligence technology to read 1 million anonymous eye scans and identify any defects in the subjects that could lead to blindness. The goal of the project is to give doctors a digitized tool to read eye-scan tests and identify any issues in patients much faster. Earlier detection of eye disorders related to health issues like diabetes and macular degeneration could cut back on vision loss for much of the affected population, the company said in a statement released on Tuesday. Alphabet, based in…

Link to Full Article: Alphabet (GOOGL) Stock Down on New Medical Technology

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!